Skip to main content
Clinical Trials/ITMCTR2000002995
ITMCTR2000002995RecruitingPhase 1

Prospective clinical study of moxibustion in the treatment of Parkinson's disease

Traditional Chinese Medicine Hospital of Bao'an District0 sitesStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional study

Eligibility Criteria

Sex
All

Inclusion Criteria

  • (1) All enrolled patients in accordance with diagnostic criteria.
  • (2) Patients with Hoehn-yahr (H-Y) grade 1 to 3.
  • (3) Patientsage under 70 years.
  • (4) Duration of Parkinson over 6 months.
  • (5) Patients take pasta hydrazine tablets at least 30 daysand the medication regimen was not adjusted.
  • (6) Patients sign informed consent.

Exclusion Criteria

  • (1) Various secondary Parkinson's syndrome, Parkinson's syndrome, and Hoehn-yahr (H-Y) > 3.
  • (2) Patients with dementia and mental disorders and unable to communicate and cooperate.
  • (3) Patient has a history of severe brain trauma and brain surgery.
  • (4) Patients have severe systemic organic diseases such as heart, lung, liver, kidney, endocrine diseases and metabolic disorders.
  • (5) Patients cannot receive moxibustion.

Investigators

Sponsor
Traditional Chinese Medicine Hospital of Bao'an District

Similar Trials

Prospective clinical study of moxibustion... | Clinical Trial